XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Earnings (Loss) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues        
Total revenues $ 153,880 $ 177,353 $ 443,207 $ 499,910
Costs and expenses        
Cost of goods sold 19,601 25,878 64,152 64,267
Research and development 22,655 19,554 68,246 56,778
Selling, general and administrative 82,700 112,314 255,079 303,249
Amortization of intangible assets 21,242 20,644 61,316 61,932
Contingent consideration expense (gain) (456) 486 (1,313) 1,894
Total costs and expenses 145,742 178,876 447,480 488,120
Operating earnings (loss) 8,138 (1,523) (4,273) 11,790
Other income (expense)        
Interest expense 0 (1,724) (2,415) (5,476)
Interest and other income, net 1,751 2,803 8,467 19,289
Total other income (expense) 1,751 1,079 6,052 13,813
Earnings (loss) before income taxes 9,889 (444) 1,779 25,603
Income tax expense (benefit) 25,865 (2,193) 1,638 (9,627)
Net earnings (loss) $ (15,976) $ 1,749 $ 141 $ 35,230
Earnings (loss) per share        
Basic (in dollars per share) $ (0.29) $ 0.03 $ 0.00 $ 0.66
Diluted (in dollars per share) $ (0.29) $ 0.03 $ 0.00 $ 0.62
Weighted average shares outstanding        
Basic (in shares) 54,608,963 53,789,674 54,498,687 53,517,838
Diluted (in shares) 54,608,963 55,034,838 55,574,922 61,543,121
Net product sales        
Revenues        
Total revenues $ 149,004 $ 172,724 $ 417,915 $ 485,647
Royalty revenues        
Revenues        
Total revenues $ 4,876 $ 4,629 $ 25,292 $ 14,263